ASX:IVX Invion (IVX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Invion Stock (ASX:IVX) 30 days 90 days 365 days Advanced Chart Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get Invion alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume471,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewInvion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.Read More… DeFi Coin on Verge of Breakout! (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Receive IVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invion and its competitors with MarketBeat's FREE daily newsletter. Email Address IVX Stock News HeadlinesBiocurious: Invion taps the power of light to zap solid tumoursOctober 29, 2024 | msn.comInvion Limited Reports Promising Cancer Trial ResultsOctober 28, 2024 | msn.comDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… November 4, 2024 | Crypto 101 Media (Ad)Invion Ltd. Issues 50 Million New Shares on ASXOctober 23, 2024 | markets.businessinsider.comInvion Expands Share Issuance and Eyes Technology RightsOctober 23, 2024 | markets.businessinsider.comHealth Check: Paradigm receives FDA guidance on proposed trial for dodgy kneesSeptember 18, 2024 | msn.comClosing Bell: ASX tracks global selloff; Yancoal and GYG amongst new ASX200 entrantsSeptember 9, 2024 | msn.comAeroVironment’s (NASDAQ:AVAV) Q2 Sales Beat Estimates But Full-Year Sales Guidance Misses ExpectationsSeptember 5, 2024 | theglobeandmail.comSee More Headlines IVX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Invion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invion investors own include Denbury Resources (DNR), Walt Disney (DIS), Carlisle Companies (CSL), Cyclone Metals Limited (CFE.AX) (CFE), Camtek (CAMT), Boston Properties (BXP) and BioSpecifics Technologies (BSTC). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:IVX CUSIPN/A CIKN/A Webwww.inviongroup.com Phone61 3 9081 6005FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,630,000.00 Net Margins-152.34% Pretax MarginN/A Return on Equity-34.28% Return on Assets-20.57% Debt Debt-to-Equity RatioN/A Current Ratio2.05 Quick Ratio18.63 Sales & Book Value Annual Sales$3.69 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow15.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,770,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.12 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (ASX:IVX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invion Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Invion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
